Markwell Clarizio LLP

Menu
Contact Us

December 2025

Patients Are A Relevant Consumer in the Trademark Confusion Analysis For Biosimilars

Trademarks /

Co-authored with Emily Johnston On November 28, 2025, the Federal Court of Appeal (Per Woods JA and Laskin JA) (“FCA”) held that the Federal Court (per Pallotta J) (“FC”) did not err in (1) enjoining Samsung Bioepis (“Samsung”) and Biogen, et al (collectively “Biogen”), as well as their licensees, from using the trademark BYOOVIZ in […]

Patients Are A Relevant Consumer in the Trademark Confusion Analysis For Biosimilars Read More »

Health Canada and FDA Move Towards A Request for Information Sharing (RIS) Program for Generic Drugs

Health Canada /

On December 1, 2025, Health Canada announced the creation of a joint program with the U.S. Food and Drug Administration (FDA) to support the establishment of a Request for Information Sharing (RIS) program for generic drugs. Specific commitments and timelines under this program have not yet been released. The RIS program is intended to facilitate

Health Canada and FDA Move Towards A Request for Information Sharing (RIS) Program for Generic Drugs Read More »